TScan is a clinical-stage biotechnology company dedicated to changing lives by developing safe and effective T-cell therapies for patients.
Our approach is based on the premise that conventional T cells provide the most effective way to fight cancer, and that by genetically reprogramming T cells with highly effective, naturally occurring T cell receptors (TCRs), we can harness the power of the human immune system to deliver life-changing therapies to patients.
We are advancing a robust pipeline of TCR-T therapy candidates derived from our proprietary platform to treat patients with heme malignancies and solid tumors
Our proprietary platform is designed to discover anti-cancer TCRs from patients with exceptional responses to immunotherapy.
We are committed to bringing new immunotherapies to cancer patients.
Chief Executive Officer
Chief Financial Officer and Treasurer
Chief Medical Officer
Chief Technology Officer
Chief Legal and Strategy Officer and Secretary
Senior Vice President, Market Access
Senior Vice President, Head of Translational Medicine
Senior Vice President, Discovery
Senior Vice President, Human Resources
Senior Vice President, Head of Quality
Senior Vice President, Head of Development Operations
